Press Release

26 April 25

CuraTeQ Biologics receives CHMP positive opinion for Dazublys – Trastuzumab biosimilar

Read more

Press Release

10 April 25

CuraTeQ Biologics successfully completes Phase I study for Denosumab biosimilar

Read more